Nov 06, 2026
EP PerMed Announces the "Cell and Gene Therapy for Personalized Medicine" Call for Proposals 2027
The EP PerMed has published its 2027 call (JTC2026), “Cell and Gene Therapy for Personalized Medicine” (CGT4PM). PerMed’s goal is to fund multinational, innovative research projects in the field of personalized medicine (PM), with the aim of bringing together academic, clinical/public health, and private-sector research teams.
The call is structured in two stages, and the available budget is approximately 38 million EUR.
Proposals must focus on the development and validation of an innovative and novel cell therapy (CGT) for PM.
Further details as well as contact at the European Project Center of TU Dresden (EPC), can be found in the EPC’s news article.